The approval was based on data from the phase 2 IMCgp100-202 trial that assessed Kimmtrak in 378 HLA-A*02:01-positive adults with previously untreated metastatic uveal melanoma. The Food and Drug ...
BetaGlue ® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing an innovative radiotherapy solution for the targeted treatment of solid tumours, ...
The pineal gland is a small endocrine gland that regulates the circadian rhythm by secreting melatonin. Tumours of the pineal ...
The use of a non-invasive procedure combined with Lenvima plus Tyvyt demonstrated safe and effective results in patients with liver cancer not eligible for surgical resection. Safe and effective ...
Retrospective analysis of overall survival in patients lost to follow-up after incidental neoplasm findings on imaging. Avelumab + sacituzumab govitecan (SG) vs avelumab monotherapy as first-line (1L) ...
Results showed treatment with osimertinib reduced the risk of disease progression or death by 84% compared with placebo. The Food and Drug Administration (FDA) has approved Tagrisso ® (osimertinib) ...
Please provide your email address to receive an email when new articles are posted on . An immunotherapy combination improved outcomes compared with historical control for certain patients with ...
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer Twenty-four patients received vismodegib; five were ...
SAN FRANCISCO -- After more than 20 years of trying, systemic therapy for unresectable liver cancer has improved outcomes with transarterial chemoembolization (TACE), a randomized trial showed.
Overall survival was better with hepatic arterial infusion chemotherapy compared with transarterial chemoembolization, according to phase 3 study findings. Patients with hepatocellular carcinoma (HCC) ...
For patients with inoperable pancreatic cancer, higher dose ablative radiation after chemotherapy induction may extend life, say investigators from Memorial Sloan Kettering Cancer Center in New York ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback